Spatio-temporal analysis of nanoparticles in live tumor spheroids impacted by cell origin and density.

Fluorescence imaging Mathematical modelling Microscopy Nanoparticles Tumor spheroids Uptake kinetics

Journal

Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908

Informations de publication

Date de publication:
01 2022
Historique:
received: 09 09 2021
revised: 18 11 2021
accepted: 08 12 2021
pubmed: 17 12 2021
medline: 23 3 2022
entrez: 16 12 2021
Statut: ppublish

Résumé

Nanoparticles hold great preclinical promise in cancer therapy but continue to suffer attrition through clinical trials. Advanced, three dimensional (3D) cellular models such as tumor spheroids can recapitulate elements of the tumor environment and are considered the superior model to evaluate nanoparticle designs. However, there is an important need to better understand nanoparticle penetration kinetics and determine how different cell characteristics may influence this nanoparticle uptake. A key challenge with current approaches for measuring nanoparticle accumulation in spheroids is that they are often static, losing spatial and temporal information which may be necessary for effective nanoparticle evaluation in 3D cell models. To overcome this challenge, we developed an analysis platform, termed the Determination of Nanoparticle Uptake in Tumor Spheroids (DONUTS), which retains spatial and temporal information during quantification, enabling evaluation of nanoparticle uptake in 3D tumor spheroids. Outperforming linear profiling methods, DONUTS was able to measure silica nanoparticle uptake to 10 μm accuracy in both isotropic and irregularly shaped cancer cell spheroids. This was then extended to determine penetration kinetics, first by a forward-in-time, center-in-space model, and then by mathematical modelling, which enabled the direct evaluation of nanoparticle penetration kinetics in different spheroid models. Nanoparticle uptake was shown to inversely relate to particle size and varied depending on the cell type, cell stiffness and density of the spheroid model. The automated analysis method we have developed can be applied to live spheroids in situ, for the advanced evaluation of nanoparticles as delivery agents in cancer therapy.

Identifiants

pubmed: 34915071
pii: S0168-3659(21)00667-2
doi: 10.1016/j.jconrel.2021.12.014
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

661-675

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Aria Ahmed-Cox (A)

Children's Cancer Institute, Lowy Cancer Research Center, UNSW Sydney, NSW 2031, Australia; ARC Center of Excellence in Convergent Bio-Nano Science and Technology, Australian Center for NanoMedicine, UNSW Sydney, NSW 2031, Australia; School of Women and Children's Health, Faculty of Medicine and Health, UNSW Sydney, NSW 2031, Australia.

Elvis Pandzic (E)

Katharina Gaus Light Microscopy Facility, Mark Wainwright Analytical Center, UNSW Sydney, NSW 2031, Australia.

Stuart T Johnston (ST)

ARC Center of Excellence in Convergent Bio-Nano Science and Technology, Systems Biology Laboratory, School of Mathematics and Statistics, and Department of Biomedical Engineering, University of Melbourne, Parkville, Victoria 3010, Australia.

Celine Heu (C)

Katharina Gaus Light Microscopy Facility, Mark Wainwright Analytical Center, UNSW Sydney, NSW 2031, Australia.

John McGhee (J)

ARC Center of Excellence in Convergent Bio-Nano Science and Technology, Australian Center for NanoMedicine, UNSW Sydney, NSW 2031, Australia; 3D Visualisation Aesthetics Lab, UNSW Art & Design, UNSW Sydney, NSW 2021, Australia.

Friederike M Mansfeld (FM)

Children's Cancer Institute, Lowy Cancer Research Center, UNSW Sydney, NSW 2031, Australia; ARC Center of Excellence in Convergent Bio-Nano Science and Technology, Australian Center for NanoMedicine, UNSW Sydney, NSW 2031, Australia; School of Women and Children's Health, Faculty of Medicine and Health, UNSW Sydney, NSW 2031, Australia; ARC Center of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Melbourne, Victoria, 3052, Australia.

Edmund J Crampin (EJ)

ARC Center of Excellence in Convergent Bio-Nano Science and Technology, Systems Biology Laboratory, School of Mathematics and Statistics, and Department of Biomedical Engineering, University of Melbourne, Parkville, Victoria 3010, Australia; School of Medicine, Faculty of Medicine Dentistry and Health Sciences, University of Melbourne, Parkville, Victoria 3010, Australia.

Thomas P Davis (TP)

Precision Medicine, Australian Institute of Bioengineering & Nanotechnology, University of Queensland, QLD, 40679, Australia.

Renee M Whan (RM)

Katharina Gaus Light Microscopy Facility, Mark Wainwright Analytical Center, UNSW Sydney, NSW 2031, Australia.

Maria Kavallaris (M)

Children's Cancer Institute, Lowy Cancer Research Center, UNSW Sydney, NSW 2031, Australia; ARC Center of Excellence in Convergent Bio-Nano Science and Technology, Australian Center for NanoMedicine, UNSW Sydney, NSW 2031, Australia; School of Women and Children's Health, Faculty of Medicine and Health, UNSW Sydney, NSW 2031, Australia. Electronic address: m.kavallaris@ccia.unsw.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH